The higher frequency of CALR mutations in prePMF compared to ET (35·8% vs 17·8%, P <·001) might contribute to the high level of platelet count observed in prePMF and to the higher frequency of extreme thrombocytosis (> 1000 × 109/L) observed in prePMF. The gene discussed is CALR; the disease is Thrombocytosis.